Abstract
Fumagillin, an antibiotic isolated from the fungus Aspergillus famigatus and first utilized in the 1950’s for its antiprotozoal and antiamoebic properties, has recently been discovered to be a potent inhibitor of blood vessel growth, termed angiogenesis. A previous study indicated that fumagillin was toxic to murine erythroleukemic cells (MEL BB-88) and HeLa cervical carcinoma cells. This study was initiated to understand what effects the chemical has on the cell surface ultrastructural morphology of these two cancer cell lines.MEL BB-88 cells were treated with 0.0, 5.0, or 10.0 μg/ml fumagillin for 24, 48, 72, and 96 hours, while HeLa cells received 0.0, 1.0, or 5.0 μg/ml fumagillin for the same time periods. Cells were fixed in 2% glutaraldehyde for two hours, postfixed in 1% osmium tetroxide for one hour, dehydrated in an ascending alcohol series, critically point dried, coated with gold palladium, and observed under an ISI Super III scanning electron microscope
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.